T. Rowe Price Investment Management, Inc. Ventyx Biosciences, Inc. Transaction History

T. Rowe Price Investment Management, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$29.8 - $40.3 $3.67 Million - $4.96 Million	123,124 Added 13.53%	1,032,846 $35.9 Million
Q2 2023 Aug 14, 2023	BUY	$28.53 - $39.55 $9.85 Million - $13.6 Million	345,086 Added 61.12%	909,722 $29.8 Million
Q1 2023 May 15, 2023	BUY	$29.51 - $46.65 $16.7 Million - $26.3 Million	564,636 New	564,636 $18.9 Million

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $135M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of T. Rowe Price Investment Management, Inc., based on Form 13F filings with the SEC.

Stay updated on T. Rowe Price Investment Management, Inc. with notifications on news.